Contract manufacturers in Korea, China and the EU often tell a new brand "we already have a CPSR for this formula." It may have been written for the factory's own product, for another client or for a similar base. That makes it a useful starting point, not automatically your report.
Who is the Responsible Person for a private label product?
For an imported product, the importer is the Responsible Person by default. Article 4(5) makes each importer the RP "for the specific cosmetic product he places on the market" and lets it designate another person established in the EU by written mandate, who must accept in writing. Without an RP designated in the EU, the product cannot be placed on the market (Art. 4(1)).
The definition of "manufacturer" in Article 2(1)(d) matters here: it covers whoever "has such a product designed or manufactured, and markets that cosmetic product under his name or trademark." In a private label deal, that is the brand, not the factory. Three common situations follow:
- Made in Korea or China, sold in the EU. The EU importer is the RP unless it mandates someone else. In practice, many non-EU brands arrange for one EU company to act as importer or receive the importer's mandate, so one RP holds all their files.
- Made by an EU contract manufacturer for a brand outside the EU. The brand must designate an EU RP by written mandate (Art. 4(4)).
- An EU distributor sells the product under its own brand. The distributor becomes the RP (Art. 4(6)).
Whoever it is, the RP answers for the safety assessment, PIF, notification and label of each product (Art. 4(2), Art. 5(1)).
Does the Regulation allow you to use a CPSR someone else prepared?
Yes. Article 10(1) requires the RP to ensure that the product "has undergone a safety assessment" and that a CPSR "is set up in accordance with Annex I", not to write the report itself. The Commission's guidelines on Annex I (Implementing Decision 2013/674/EU) expect an RP who is not the manufacturer to involve "the manufacturer, the suppliers of raw materials, and other technical experts". They also allow Part A data from "any reliable source", including "available data on similar formulations", if the report shows why the data are relevant.
The same guidelines set the limit: the assessment is done "for each individual cosmetic product", and the signature links "the assessor, the formulation and the date of assessment." So the question is fit, not permission. Responsibility stays with the RP whoever wrote the report: corrective action, withdrawal or recall are its duty (Art. 5(2)).
When does a manufacturer's existing CPSR cover your product?
A manufacturer's CPSR covers your product only when everything Annex I asks about is the same for the product you sell. Check five points:
- Formula. The exact composition matches, including the fragrance, whose name, code and supplier Annex I Part A 1 requires. The guidelines also ask for evidence that the composition tested for stability "corresponds to the product actually placed on the market".
- Packaging. Part A 4 covers the packaging material in contact with the product, and the guidelines note that new packaging may need more evaluation.
- Use and users. Part A 5 and 6 describe the intended use, application site, amount and target population. A product repositioned for children under three needs a specific assessment (Annex I Part B 3).
- Label. The warnings set in Part B 2 must appear on your label (Art. 19(1)(d)) and match the use described in the report.
- Signature and current law. The signatory is qualified under Article 10(2), and the report reflects current rules. The Commission's Blue Guide explains that placing on the market refers to each individual unit, not to a product type, so units placed after new requirements apply must meet them.
If all five match, the safety content can be reused, provided your RP has the right to keep the report in the PIF and show it to an authority (Art. 11(3), Art. 5(3)).
What changes require an updated assessment?
The guidelines (section 4.3.2) call for a review, and an update where necessary, when the formulation, raw-material specifications, conditions of use or the law change, and when new toxicological data or more undesirable effects appear. Article 10(1)(c) requires the CPSR to be kept up to date. For private label, the usual triggers are another fragrance, a new pack material, new claims, a new target group or new directions.
What you can reuse and what must be redone
| Element | Reuse when | Redo or check when |
|---|---|---|
| Formula, raw-material specs, SDS (Part A 1–2) | Formula identical | Any ingredient, percentage or grade changes |
| Fragrance documents | Same fragrance, same level | New fragrance |
| Ingredient toxicology (Part A 8) | Mostly reusable | Amount, site or users change |
| Stability, challenge test (Part A 2–3) | Same formula, same or comparable pack | Formula or pack changes |
| Packaging material (Part A 4) | Identical primary pack | Material in contact changes |
| Use and target group (Part A 5–6) | Same directions and users | New users or directions |
| Part B: conclusion, warnings, signature | Every row above identical | Otherwise: reviewed and signed for your product |
| Manufacturing method, GMP (Art. 11(2)(c)) | Same factory | Production moves |
| Proof of claims (Art. 11(2)(d)) | Studies on your exact formula | New claims |
| Label | Never | Always yours: RP, origin, warnings (Art. 19(1)) |
| PIF and CPNP notification | Never | Always your RP's (Art. 11, 13) |
What should you ask your manufacturer for?
Ask for the documents the assessor needs to check the fit, not only the report:
- the full quantitative formula, with INCI name, CAS number and exact percentage of every raw material (the guidelines allow ranges only where justified);
- raw-material specifications and safety data sheets, including the composition of blends;
- fragrance documents: the IFRA conformity statement and the allergen declaration;
- the finished-product specification, the stability study with the packaging used, and the challenge test;
- packaging material information and compatibility data;
- the manufacturing method description and GMP statement;
- undesirable-effects data from markets where the formula is sold;
- the existing CPSR, with the assessor's name, proof of qualification, date and signature (Annex I Part B 4);
- written permission (a letter of access) for your RP to keep that CPSR in the PIF and show it to authorities, plus an agreement on who updates it.
The letter of access is practice, not a term of the Regulation. The RP must keep the PIF readily accessible (Art. 11(3)) and hand over documents on request (Art. 5(3)), and it can do that with someone else's report only with their consent. Our document checklist shows who holds each document.
What if the manufacturer won't share the formula?
Formula confidentiality is normal in OEM and ODM production and does not block the assessment. The manufacturer can send the formula and documents directly to the safety assessor under a non-disclosure agreement; the brand never needs to see them. The guidelines accept a similar route for fragrances: where a fragrance's composition is confidential, its supplier may provide a safety assessment to the RP.
One condition remains. The PIF, including the CPSR with the full composition, must be available to the authority at the RP's address (Art. 11(3)). Agree in writing, before the first shipment, how the RP gets access if an authority asks.
Several brands use the same base formula. Does each need its own PIF?
Yes. The RP keeps a PIF for each product it places on the market (Art. 11(1)) and notifies it in the CPNP beforehand (Art. 13(1)). Two brands selling the same cream mean two products, two PIFs and two notifications, even when one RP handles both.
The safety data can be shared. The guidelines allow Part A data from similar formulations, and undesirable-effects data may be used "to establish the safety assessment for similar products." A typical case is one base cream sold under several brands with different fragrances. Most of Part A can be shared; the fragrance section, allergen labelling, warnings and Part B are done per product, because that is where the products differ. What is in a CPSR explains each part.
If you already have a manufacturer's CPSR, send it with your label using the form below, and we will tell you which parts fit your product.
FAQ
Is my manufacturer's CPSR a certificate?
No. No authority issues or approves a CPSR. It is a safety report inside the PIF, signed by a qualified assessor for a specific formulation and date, and what counts is whether it covers the product your RP places on the market.
Does the CPSR have to name my brand or my Responsible Person?
Annex I does not list the RP among the contents of a CPSR. The PIF, however, must clearly attribute the file to your product (Art. 11(2)(a)), and your RP's name and address must be on the label (Art. 19(1)(a)) and in the notification (Art. 13(1)(b)). In practice, the assessor issues a version of the report under your product name.
Can my EU contract manufacturer act as my Responsible Person?
Yes, if you designate it by written mandate and it accepts in writing (Art. 4(4)). A brand outside the EU that has a product made and sells it under its own trademark is the manufacturer in the legal sense (Art. 2(1)(d)), so the designation is the brand's decision.
My EU distributor only translates the label. Does it become the Responsible Person?
No. Under Article 4(6), translating information about a product already on the market is not a modification that makes the distributor the RP. A distributor that translates labelling on its own initiative must, however, submit certain information to the CPNP (Art. 13(3)).
Sources
- Regulation (EC) No 1223/2009 on cosmetic products, Articles 2, 4, 5, 10, 11, 13, 19 and Annex I
- Commission Implementing Decision 2013/674/EU: guidelines on Annex I (the CPSR)
- The "Blue Guide" on the implementation of EU product rules 2022, section 2.3 (placing on the market)